Ryan Scott - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Ryan Scott's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Ryan Scott
Verified
Assistant Editor, OncLive
Cranbury
Beats
patient safetyHealthcare healthcare quality
Content
By Ryan Scott Verified| Oncology Nursing News Verified Men with intermediate-risk prostate cancer and high prostate-specific antigen (PSA) levels before high-intensity focused ultrasound (HIFU) treatment faced a greater risk of recurrence and treatment failure, according to research presented at the 2025 ASCO Genitourinary Cancers Symposium. In this investigation of 108 men with intermediate-risk prostate cancer following HIFU, investigators found that in-field and overall recurrence on 1-year biopsy was 41% and 54%, respectively.
By Ryan Scott Verified| Targeted Oncology Verified Research presented in a poster at the 2025 ASCO Genitourinary Cancers Symposium found that high prostate-specific antigen (PSA) levels before High-Intensity Focused Ultrasound (HIFU) were associated with a greater risk of overall recurrence and treatment failure in patients with intermediate-risk prostate cancer.
By Ryan Scott Verified| Oncology Nursing News Verified Men with intermediate-risk prostate cancer and high prostate-specific antigen (PSA) levels before high-intensity focused ultrasound (HIFU) treatment faced a greater risk of recurrence and treatment failure, according to research presented at the 2025 ASCO Genitourinary Cancers Symposium. In this investigation of 108 men with intermediate-risk prostate cancer following HIFU, investigators found that in-field and overall recurrence on 1-year biopsy was 41% and 54%, respectively.
Company Info
OncLive
NeurologyLive is a multimedia platform focused on delivering the latest news and insights in the field of neurology. It serves as a valuable resource for healthcare professionals, particularly those treating neurological diseases. The platform offers a combination of print and digital media, ensuring that busy clinicians stay informed about significant developments in neurology. The services provided by NeurologyLive include breaking news on drug approvals, clinical trials, and emerging trends in neurological care. It features expert interviews with leading neurologists, offering insights into the latest research and clinical practices. The use of multimedia content makes the information accessible and engaging for its audience. NeurologyLive targets healthcare professionals such as neurologists, clinicians, and researchers. It has established strategic partnerships with organizations like the Consortium of Multiple Sclerosis Centers, enhancing its credibility and reach within the neurology community. Its comprehensive coverage and expert engagement position NeurologyLive as a trusted source for the latest developments in the field.
Cranbury, United States
+1 609-716-7777
Founded: 2018